is tirzepatide being discontinued A Major GLP-1 Drug Shortage Over. Some Patients Aren't Celebrating tirzepatide being discontinued In a

Semaglutide use and weight loss Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that Three brand names for semaglutide have been approved by the Food and Drug Administration (FDA) for different purposes: Wegovy: FDA-approved for weight loss and reducing the risk of cardiovascular disease

Fatigue appears in 8-12% of users, though distinguishing medication-induced fatigue from diet-related energy deficits proves difficult

The most common: Nausea, especially in the first few weeks and after dose increases

Target ferritin levels above 40 ng/mL (some dermatologists recommend 70+ for optimal hair growth)